Christopher Ogden, CFO of CytomX Therapeutics CTMX, has filed 0 purchases and 9 sales on the open market. Over the past 12 months that comes to a net sale of $129K. The latest trade was on 06/15.

CO

CO

Christopher Ogden

CFO

Company

CytomX Therapeutics CTMX

First filing

23/02/06

Trades

31 trades

Buys / sales

0 / 9

12-month net buying

−$129K

Last trade

06/15

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
CytomX TherapeuticsCTMX	Open-market sale	06/15	06/17	1,624 sh	$3.05	$4,953.2	−0.5%
CytomX TherapeuticsCTMX	Open-market sale	03/17	03/19	19,323 sh	$6.42	$124,053.66	−6.1%
CytomX TherapeuticsCTMX	Open-market sale	25/06/13–25/06/16	25/06/17	12,255 sh2 trades	$2.72avg.	$33,392.61	−5.1%
CytomX TherapeuticsCTMX	Open-market sale	25/03/18	25/03/20	8,551 sh	$0.60	$5,130.6	−4.1%
CytomX TherapeuticsCTMX	Open-market sale	24/08/20	24/08/22	1,984 sh	$1.23	$2,440.32	−1.8%
CytomX TherapeuticsCTMX	Open-market sale	24/03/19	24/03/21	2,971 sh	$2.09	$6,209.39	−3.4%
CytomX TherapeuticsCTMX	Open-market sale	23/12/20	23/12/22	1,990 sh	$1.38	$2,746.2	−3.9%
CytomX TherapeuticsCTMX	Open-market sale	23/03/16	23/03/20	516 sh	$1.98	$1,021.68	−1.3%